R&G PharmaStudies Co (SZSE:301333) Days Payable : 35.45 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is R&G PharmaStudies Co Days Payable?

R&G PharmaStudies Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥42.8 Mil. R&G PharmaStudies Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥110.2 Mil. Hence, R&G PharmaStudies Co's Days Payable for the three months ended in Mar. 2024 was 35.45.

The historical rank and industry rank for R&G PharmaStudies Co's Days Payable or its related term are showing as below:

SZSE:301333' s Days Payable Range Over the Past 10 Years
Min: 4.75 Med: 15.84 Max: 34.66
Current: 34.66

During the past 10 years, R&G PharmaStudies Co's highest Days Payable was 34.66. The lowest was 4.75. And the median was 15.84.

SZSE:301333's Days Payable is ranked worse than
80.89% of 717 companies
in the Biotechnology industry
Industry Median: 147.46 vs SZSE:301333: 34.66

R&G PharmaStudies Co's Days Payable increased from Mar. 2023 (30.89) to Mar. 2024 (35.45). It may suggest that R&G PharmaStudies Co delayed paying its suppliers.

R&G PharmaStudies Co Days Payable Historical Data

The historical data trend for R&G PharmaStudies Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R&G PharmaStudies Co Days Payable Chart

R&G PharmaStudies Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

23.10

25.28

28.51

30.70

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															30.89	30.96	39.39	34.32	35.45

Competitive Comparison of R&G PharmaStudies Co's Days Payable

For the Biotechnology subindustry, R&G PharmaStudies Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Days Payable distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's Days Payable falls into.

R&G PharmaStudies Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

R&G PharmaStudies Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (32.204	+	40.866)	/	2 )	/	434.335	*	365
=	36.535					/	434.335	*	365
=	30.70

R&G PharmaStudies Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (40.866	+	44.79)	/	2 )	/	110.231	*	365 / 4
=	42.828					/	110.231	*	365 / 4
=	35.45

R&G PharmaStudies Co Days Payable Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » R&G PharmaStudies Co Ltd (SZSE:301333) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048

Website

R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

R&G PharmaStudies Co (SZSE:301333) Headlines

No Headlines